Qbex Clinical GmbH is a clinical and regulatory consultancy company that was established by Dr. Alexander Hoenel in Austria in 2014, and enlarged for clinical development in 2018. QBEX provides regulatory services to the biotech and pharma industry that span all phases of clinical development, classical CRO services as well as training and assistance in the start up process of Pharmaceuticals and Medical Devices, Audits and QA.
Within the OSTEOproSPINE project, QBEX is mainly involved in the work package that involves regulatory support for the proposed clinical study.